News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
647,261 Results
Type
Article (40263)
Company Profile (217)
Press Release (606781)
Section
Business (186672)
Career Advice (2789)
Deals (34456)
Drug Delivery (95)
Drug Development (77232)
Employer Resources (165)
FDA (16024)
Job Trends (15261)
News (322791)
Policy (31246)
Tag
Academia (2676)
Alliances (46227)
Alzheimer's disease (1279)
Approvals (15953)
Artificial intelligence (141)
Bankruptcy (310)
Best Places to Work (12101)
Biotechnology (126)
Breast cancer (119)
Cancer (1064)
Cardiovascular disease (100)
Career advice (2322)
Cell therapy (243)
Clinical research (61405)
Collaboration (389)
Compensation (196)
COVID-19 (2498)
C-suite (102)
Data (1140)
Diabetes (150)
Diagnostics (6432)
Earnings (72744)
Employer resources (145)
Events (105758)
Executive appointments (324)
FDA (16561)
Funding (351)
Gene therapy (181)
GLP-1 (548)
Government (4162)
Healthcare (19817)
Infectious disease (2576)
Inflammatory bowel disease (113)
Interviews (537)
IPO (16346)
Job creations (3550)
Job search strategy (1942)
Layoffs (409)
Legal (7250)
Lung cancer (164)
Manufacturing (181)
Medical device (13857)
Medtech (13862)
Mergers & acquisitions (18237)
Metabolic disorders (376)
Neuroscience (1561)
NextGen Class of 2024 (6874)
Non-profit (4826)
Northern California (1506)
Obesity (204)
Opinion (219)
Patents (104)
People (54369)
Phase I (18955)
Phase II (27236)
Phase III (20361)
Pipeline (453)
Postmarket research (2240)
Preclinical (7938)
Radiopharmaceuticals (248)
Rare diseases (234)
Real estate (5451)
Regulatory (21114)
Research institute (2461)
Resumes & cover letters (451)
Southern California (1325)
Startups (3313)
United States (13727)
Vaccines (507)
Weight loss (140)
Date
Today (136)
Last 7 days (819)
Last 30 days (3919)
Last 365 days (36864)
2024 (33783)
2023 (41612)
2022 (52741)
2021 (57473)
2020 (56080)
2019 (49276)
2018 (37183)
2017 (33205)
2016 (31894)
2015 (37211)
2014 (27749)
2013 (22418)
2012 (23887)
2011 (24577)
2010 (21758)
Location
Africa (824)
Arizona (133)
Asia (39045)
Australia (6657)
California (3345)
Canada (1284)
China (246)
Colorado (150)
Connecticut (162)
Europe (86756)
Florida (467)
Georgia (125)
Illinois (348)
Indiana (203)
Kansas (94)
Maryland (569)
Massachusetts (2709)
Michigan (174)
Minnesota (274)
New Jersey (965)
New York (962)
North Carolina (760)
Northern California (1506)
Ohio (143)
Pennsylvania (850)
South America (1184)
Southern California (1325)
Texas (470)
Utah (95)
Washington State (369)
647,261 Results for "innate pharmaceuticals ab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Innate Pharma Highlights Abstracts Selected for EHA 2024 Congress
Innate Pharma SA announced that four abstracts with Innate’s drug candidates have been accepted for the European Association of Hematology 2024 Congress, taking place June 13-16, 2024 in Madrid, Spain.
May 15, 2024
·
6 min read
Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting
Regulatory News: Innate Pharma SA announced that five abstracts with Innate’s drug candidates have been accepted for the American Society of Clinical Oncology 2024 Annual Meeting, taking place May 31-June 4, 2024 in Chicago, Illinois.
May 24, 2024
·
5 min read
Press Releases
Innate Pharma Releases Its 2025 Financial Calendar
November 20, 2024
·
4 min read
Innate Pharma: Clarification Regarding SAR443579 Designation
Innate Pharma SA announced that in an abstract published on 14 May 2024 for the European Hematology Association 2024 Congress on SAR443579/IPH6101, submitted by Sanofi, it was mentioned that the molecule received breakthrough designation.
May 21, 2024
·
4 min read
Press Releases
Innate Pharma Reports Third Quarter 2024 Business Update and Financial Results
November 13, 2024
·
12 min read
Press Releases
Innate Pharma Announces Its Participation in Upcoming Investor Conferences
October 29, 2024
·
4 min read
Press Releases
AB Science: Revenues for the first half of 2024 and update on AB Science’s activities
October 10, 2024
·
21 min read
Outcome of Innate Pharma’s 2024 Annual General Meeting
Innate Pharma SA announced the voting results of its shareholders at the Annual General Meeting, which took place on May 23, 2024, in Marseille.
May 23, 2024
·
3 min read
Press Releases
Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET® IPH6501
November 19, 2024
·
6 min read
Deals
Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company
Asahi Kasei Corp. announces that it will offer the shareholders of Calliditas Therapeutics AB to acquire the shares of the pharmaceutical company Calliditas for the purpose of making Calliditas a wholly-owned subsidiary of Asahi Kasei through a voluntary tender offer for Calliditas.
May 28, 2024
·
7 min read
1 of 64,727
Next
